What is benign prostate enlargement?
Benign prostate enlargement, also known as benign prostatic hyperplasia (BPH), is a common condition affecting men as they age. Around 50% of men over 50 and up to 80% of men over 80 suffer from an enlarged prostate. But what exactly is benign prostate enlargement, and what are the symptoms?
What is CoreTherm®?
CoreTherm® is a non-surgical treatment for men with benign prostate enlargement. The procedure takes less than 15 minutes and is performed under local anesthesia. Studies show that CoreTherm® provides symptom relief comparable to traditional surgery (TURP), but with a lower risk of serious complications. Learn more about what CoreTherm® is and how the treatment works.
What is CoreTherm®?
CoreTherm® is a non-surgical treatment for men with benign prostate enlargement. The treatment uses microwaves to reduce the size of the prostate and alleviate symptoms. It provides symptom relief comparable to traditional surgery but with a lower risk of serious complications.
Disclaimer: This product is not cleared, approved, or authorized by the U.S. Food and Drug Administration (FDA) and is not available for sale or distribution in the United States. It is only available in select markets in accordance with local regulatory requirements.
CoreTherm® is a non-surgical treatment for men with benign prostate enlargement and urinary symptoms. It is a common condition in men over the age of 60. As the prostate enlarges, it can press against the urethra, making urination difficult.
During a CoreTherm® treatment, parts of the prostate gland are heated using microwaves. The heat causes prostate cells to die. After the treatment, the body naturally removes the dead tissue, causing the prostate to shrink. The pressure on the urethra is relieved, and urinary symptoms are eliminated.
CoreTherm® is a Swedish innovation that has been developed over more than 25 years. Studies have shown that CoreTherm® provides symptom relief comparable to traditional surgery (TURP/resection) but with a lower risk of serious complications.¹ Over 30,000 CoreTherm® treatments have been performed.
1.Mattiasson A. et al. Urology 2007;69(1):91-96.